Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Hearing Loss, Conductive
Total 0 results
Nothing found
Sponsors and Collaborators
Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
Dr Philippe METELLUS
Glasgow Western Infirmary
Åke Wibergs Stiftelse
ECMC
IRCCS Istituto Auxologico Italiano, Milano, Italy
Sublimity Therapeutics Holdco Limited
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Sahachat Aueyingsak
National Institute of Cardiovascular Diseases, Bangladesh
Daniela Pacella - University of Naples Federico II, Naples
Hospitales Universitarios Virgen del Rocío
Bassam Abdulkarim
Centro Universitário Franciscano
The Australia-Israel Scientific Exchange Foundation (AISEF)
the people hospital of Linzhi
Etan Orgel
AlpinARC
Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
View Full List
Medical Conditions
Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
Legal History
Value-Based Health Insurance
Patients With Leptomeningeal Disease
Interviews
Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
Eosinophil Blood Count
Very Long Chain Acyl Coa Dehydrogenase Deficiency
Orthopaedic Disorders
Panniculectomy
Hyperprolinemia
Pancreaticoduodenectomy
Initiation of Depo-Provera (DMPA)
Bladder Cancer TNM Staging Primary Tumor (T) T2B
Progression to PD-1 Antibody
Adult Patients Undergoing Surgery That Requires General Anesthesia
Transitional Cell Carcinoma of Renal Pelvis
Genetic Risk Factor
Degenerative Spondylolisthesis G1
Ability to Swim 100m Independent Freestyle
View Full List
Drug Interventions
IV rtPA (intravenous recombinant plasminogen activator)
UFUR and Iressa
ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
Omeprazole 20mg
0% N2O
HBM4003 and Triprilimab
Paliperidone palmitate
Metoclopramide + dexamethasone
Gefitinib
ASP8062
Epirubicin hydrochloride
Mepivacaine
Injectable Insulin
Prasugrel
6% hetastarch
Cefuroxime 750mg oral
Nimotuzumab
5-Fluoro-uracil
Erythropoietin
Antibiotic treatment
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Bahrain
Contract Research Organizations in Burundi
Contract Research Organizations in Cambodia
Contract Research Organizations in France
Contract Research Organizations in Kosovo
Contract Research Organizations in Latvia
Contract Research Organizations in Malaysia
Contract Research Organizations in New Zealand
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Sri Lanka
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in United Arab Emirates
CRO list by country
CROs in Azerbaijan
ROSENBAUM GROUP
SGS
BiTrial Clinical Research
All CROs in Azerbaijan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe